Stay updated on LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.

Latest updates to the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page
- Check2 days agoChange DetectedAdded a Locations section listing multiple sites across China (Beijing Municipality, Guangdong, Henan, Hubei, Hunan, Jiangsu, Jilin, Liaoning, Nanjing, Shanghai Municipality, Sichuan, Yunnan).SummaryDifference1%

- Check9 days agoChange DetectedRemoved 'Type 1 diabetes' and the related topic 'MedlinePlus Genetics' from the page's related topics.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page now lists 'Type 1 diabetes' as a related topic and includes a related topic to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page footer, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedA new note states that PubMed-listed publications are auto-filled and may not all relate to the study, and the page now shows revision: v3.3.1; the older PubMed wording and revision v3.2.0 have been removed.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the general government funding and operating status notice. This does not affect the study details, eligibility criteria, or data presented on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2963016 vs Lantus in Chinese Type 1 Diabetes Clinical Trial page.